182 related articles for article (PubMed ID: 26270111)
1. Individualizing factor replacement therapy in severe hemophilia.
Carcao MD; Iorio A
Semin Thromb Hemost; 2015 Nov; 41(8):864-71. PubMed ID: 26270111
[TBL] [Abstract][Full Text] [Related]
2. Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.
Iorio A; Iserman E; Blanchette V; Dolan G; Escuriola Ettingshausen C; Hermans C; Negrier C; Oldenburg J; Reininger A; Rodriguez-Merchan C; Spannagl M; Valentino LA; Young G; Steinitz-Trost KN; Gringeri A
Haemophilia; 2017 May; 23(3):e170-e179. PubMed ID: 28345268
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges.
Coppola A; Tagliaferri A; Di Capua M; Franchini M
Semin Thromb Hemost; 2012 Feb; 38(1):79-94. PubMed ID: 22314606
[TBL] [Abstract][Full Text] [Related]
4. Individualizing prophylaxis in hemophilia: a review.
Petrini P; Valentino LA; Gringeri A; Re WM; Ewenstein B
Expert Rev Hematol; 2015 Apr; 8(2):237-46. PubMed ID: 25600578
[TBL] [Abstract][Full Text] [Related]
5. Targeting factor replacement therapy in severe hemophilia: which level is important?
Fischer K; Berntorp E
Semin Thromb Hemost; 2015 Nov; 41(8):860-3. PubMed ID: 26451746
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis for severe hemophilia: experience from Europe and the United States.
van den Berg HM; Fischer K
Semin Thromb Hemost; 2003 Feb; 29(1):49-54. PubMed ID: 12640565
[TBL] [Abstract][Full Text] [Related]
7. Impact of an individualized prophylaxis approach on young adults with severe hemophilia.
Fernandes S; Carvalho M; Lopes M; Araújo F
Semin Thromb Hemost; 2014 Oct; 40(7):785-9. PubMed ID: 25313523
[TBL] [Abstract][Full Text] [Related]
8. Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
Ljung R; Auerswald G; Benson G; Jetter A; Jiménez-Yuste V; Lambert T; Morfini M; Remor E; Sørensen B; Salek SZ
Haemophilia; 2013 Jul; 19(4):481-6. PubMed ID: 23387528
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII therapy for hemophilia A: current and future issues.
Aledort L; Ljung R; Mann K; Pipe S
Expert Rev Hematol; 2014 Jun; 7(3):373-85. PubMed ID: 24717090
[TBL] [Abstract][Full Text] [Related]
10. Changing paradigm of prophylaxis with longer acting factor concentrates.
Carcao M
Haemophilia; 2014 May; 20 Suppl 4():99-105. PubMed ID: 24762284
[TBL] [Abstract][Full Text] [Related]
11. Is Continuous Low-Dose Prophylaxis Superior to On-Demand Treatment for Patients with Hemophilia?
Windyga J
Semin Thromb Hemost; 2016 Jul; 42(5):533-40. PubMed ID: 27096764
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis in real life scenarios.
Fischer K; Konkle B; Broderick C; Kessler CM
Haemophilia; 2014 May; 20 Suppl 4():106-13. PubMed ID: 24762285
[TBL] [Abstract][Full Text] [Related]
13. Climbing therapy under PK-tailored prophylaxis.
Stemberger M; Schmit E; Czepa D; Kurnik K; Spannagl M
Hamostaseologie; 2014; 34 Suppl 1():S13-6. PubMed ID: 25382764
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis in bleeding disorders.
Oldenburg J
Thromb Res; 2011 Jan; 127 Suppl 1():S14-7. PubMed ID: 21112077
[TBL] [Abstract][Full Text] [Related]
15. Assessment of treatment practice patterns for severe hemophilia A: a global nurse perspective.
Khair K; Lawrence K; Butler R; O'Shea E; Christie BA
Acta Haematol; 2008; 119(2):115-23. PubMed ID: 18367832
[TBL] [Abstract][Full Text] [Related]
16. Personalized prophylaxis.
Collins PW
Haemophilia; 2012 Jul; 18 Suppl 4():131-5. PubMed ID: 22726096
[TBL] [Abstract][Full Text] [Related]
17. Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis.
Ross C; Goldenberg NA; Hund D; Manco-Johnson MJ
Pediatrics; 2009 Nov; 124(5):1267-72. PubMed ID: 19822585
[TBL] [Abstract][Full Text] [Related]
18. Methods for individualising factor VIII dosing in prophylaxis.
Ar MC; Vaide I; Berntorp E; Björkman S
Eur J Haematol Suppl; 2014 Aug; 76():16-20. PubMed ID: 24957103
[TBL] [Abstract][Full Text] [Related]
19. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
Dodd C; Watts RG
Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
[TBL] [Abstract][Full Text] [Related]
20. Central venous access devices in patients with hemophilia.
Valentino LA; Kapoor M
Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
